Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12618001211257
ACTRN12618001211257
Completed
未知

Determination of clinical factors that influence insulin dose requirements during treatment of hyperglycaemia while taking prednisolone

Flinders Medical Centre0 sites50 target enrollmentJuly 19, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPrednisolone induced hyperglycaemiaInsulin resistanceMetabolic and Endocrine - DiabetesMetabolic and Endocrine - Other metabolic disorders

Overview

Phase
未知
Intervention
Not specified
Conditions
Prednisolone induced hyperglycaemia
Sponsor
Flinders Medical Centre
Enrollment
50
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 19, 2018
End Date
August 30, 2021
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Age greater than or equal to 18 years
  • •2\. Prescribed a morning dose of oral prednisolone greater than or equal to 20 mg/day for an acute inflammatory illness.
  • •3\. Hyperglycaemia in the prior 24 hours, defined as:
  • •A) One point\-of\-care blood glucose greater than or equal to 15 mmol/L.
  • •B) Two point\-of\-care blood glucose greater than or equal to 10 mmol/L.

Exclusion Criteria

  • •1\. by mouth or reduced oral intake.
  • •2\. Type 1 diabetes mellitus (T1DM).
  • •3\. Prescribed long\-term oral prednisolone greater than or equal to 10 mg/day (or equivalent).
  • •4\. Psychiatric illness or another condition precluding providing informed consent.
  • •5\. Pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A study to identify factors that affect clinical trial participation and refusal in breast cancer patients by using a questionnaire
JPRN-UMIN000021243SELECT BC-CONFIRM executive committee177
Completed
Not Applicable
Clinical decision making in intensive care units for starting early rehabilitation.
ACTRN12616000963426Associate Professor Sue Berney1,420
Active, not recruiting
Not Applicable
Identification of risk factors and clinical characteristics of drug-induced Parkinsonism through big data analysis to provide strategies to decrease its incidenceDiseases of the nervous system
KCT0002076Hallym University Medical Center300
Completed
Not Applicable
Investigation of factors affecting patients' preference of biologics treatment modes with rheumatoid arthritisrheumatoid arthritis
JPRN-UMIN000042203Mitsubishi Tanabe Pharma Corporation400
Recruiting
Not Applicable
Analysis of factors affecting the clinical results of the toric intraocular lensCataract
JPRN-UMIN000009666San-eikai Tsukazaki Hospital200